Company news

Delivra Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Harvest One and Delivra Provide Update on Closing Date of Transaction

June 28, 2019

Delivra Announces Q1 2019 Results

May 30, 2019

Delivra Announces Record Sales For 2018

April 11, 2019

Harvest One Acquires Delivra to Strengthen its Medical and Wellness Division

March 4, 2019

Delivra Publishes Positive Results Utilizing its Unique Platform Technology for Topical Doxycycline

February 6, 2019

Delivra publishes positive results utilizing its novel platform technology for Varicose Veins

January 8, 2019

Delivra publishes positive results using its platform technology for topical Advil(TM) (ibuprofen) and Celebrex(TM) (celecoxib)

December 11, 2018

View from the C-Suite: Dr. Joseph Gabriele, Chief Executive Officer, Delivra Corp., tells his company's story. Filmed on November 27, 2018

November 27, 2018

Delivra Achieves Record Third Quarter 2018 Revenues

November 19, 2018

Ernst & Young Names Dr. Joseph Gabriele of Delivra - Entrepreneur of the Year 2018 Ontario Award in the Health Care Category

October 30, 2018

Delivra Announces Stock Option Grant and Postponement of Warrant Expiry

October 15, 2018

Delivra Receiving Interest for its Expertise and Technology for Use in the Cannabis and Pharma Industries

October 1, 2018

Delivra announces appointment of Chief Financial Officer

August 27, 2018

Delivra achieves record second quarter 2018 results

August 20, 2018

Delivra Announces First Quarter Financial Results

May 22, 2018

Delivra Exposes that the Cannabis Market Requires Further Standardization and Rigourous Testing

May 3, 2018

Delivra's Successful Product Development Strategy Yields Product Line Expansions - Including Cannabis-Related Products

April 26, 2018

Delivra successfully demonstrates targeted pain relief with topical ibuprofen

April 24, 2018

Delivra Publishes Pivotal Results on the Cholesterol & Lipid Lowering Agent Berberine

April 18, 2018

Delivra announces 20% sales growth for 2017

April 10, 2018

Delivra Corp. Completes $1,246,498.20 Non-Brokered Financing

April 5, 2018

Delivra Signs Distribution Agreement With NKS Health for Ready to Market Compounded Finished Products to Medical Doctors

February 1, 2018

Delivra signs a joint venture with Intervivo Solutions for a ready to market sleep and anti-anxiety topical therapeutic cream for the animal health industry

January 25, 2018

Delivra develops a revolutionary topical cream utilizing cannabis and opioid molecules for safer delivery in patients with chronic pain and anxiety

January 16, 2018